Harry Santamaki
Venture Partner @ Voima Ventures
Helsinki, Finland
Harry Santamaki is a pre-seed investor at Voima Ventures in Helsinki focused on SaaS and AgTech. Harry Santamaki - Venture Partner @ Voima Ventures
- Total investments:
- 3
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries Harry Santamaki invests in
Stages Harry Santamaki invests in
Countries Harry Santamaki invests in
Investment Focus
Industry
- SaaS 1 (33%)
- AgTech 1 (33%)
- Farming 1 (33%)
- Agriculture 1 (33%)
- Animal Feed 1 (33%)
Stage
- Pre-Seed 2 (67%)
- Seed 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Adamant Health
|
Adamant Health’s unique technology to analyse Parkinson’s disease symptoms is based on over 15 years of academic research at the University of Eastern Finland. With the technology, clinicians have several days detailed visibility to the patient’s symptoms and is able to optimise the treatment accordingly. Pharma companies benefit from the objectiveand long-term RW data in their clinical and post market studies and can utilise it as complementary diagnostics tool for personalised medication. | $2.3M / Seed / Jun 13, 2022 | |
Manna Insect
|
Manna Insect’s value lies in our shared expertise and our innovative, locally adaptable environmental control technology for insect farming. Intelligent software, cloud services, and specialized hardware will ensure maximum efficiency in converting waste into high-protein animal feed and organic fertilizer. This is achieved through fully locallybuilt farming units designed for optimal insect growth and mating.Manna Insect also services its clients with a digital platform, the Insect Farm Hub, which offers insect farming training, knowledge base, an AI mentor, business and production calculators, a farm nanagement tool, an interface for Manna Insect's climatization technology, and a marketplace for insect farming products and services. | $138K / Pre-Seed / Jan 01, 2020 | |
|
Adamant Health
|
Adamant Health’s unique technology to analyse Parkinson’s disease symptoms is based on over 15 years of academic research at the University of Eastern Finland. With the technology, clinicians have several days detailed visibility to the patient’s symptoms and is able to optimise the treatment accordingly. Pharma companies benefit from the objectiveand long-term RW data in their clinical and post market studies and can utilise it as complementary diagnostics tool for personalised medication. | Pre-Seed |
Co-Investors
About Voima Ventures
Voima Ventures’ mission is to solve major global problems by combining science, entrepreneurship, and value adding capital. They shed light on the ideas and technology which require time and courage to build. Industry domains include bio and new materials, medical technologies and life sciences, imaging and optics, IoT and electronics, robotics,software & ICT and AI. In addition, Voima Ventures has invested in more than 30 deep tech startups, including companies like Solar Foods, Infinited Fiber Company, and Dispelix. Cornerstone investors are VTT Technical Research Centre of Finland and European Investment Fund (EIF), backed by Finnish private and institutional investors.
Voima Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Harry Santamaki
Venture Partner
|
|||
Inka Mero
Founder & Manging Partner
|
|||
Jussi Sainiemi
Partner
|
|||
Mikko Kumpulainen
Partner
|
|||
Pontus Strahlman
Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Harry Santamaki invest in?
Harry Santamaki invests primarily in SaaS, AgTech and Farming startups, most often at Pre-Seed and Seed stage. Most of the 3 investments tracked by Shizune back companies in Finland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Harry Santamaki last invest?
The most recent investment recorded for Harry Santamaki closed in Jun 2022. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
